Tag: percutaneous transluminal angioplasty
WAVE trial update reports sustained 12-month survival benefit
Twelve-month results from the WRAPSODY Arteriovenous Access Efficacy (WAVE) pivotal trial show a statistically significant improvement in target lesion primary patency (TLPP) with the...
XO Score scoring sheath platform gains CE mark to treat PAD...
Transit Scientific has announced CE mark clearance for its XO Score scoring sheath platform, allowing the technology to be used in the treatment of...